InTec
- Company typePrivate
- Founded1989
- HeadquartersXiamen, China
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
InTec firmographics
Firmographics- Name
- InTec
- Legal name
- InTec PRODUCTS, INC.
- Website
- https://intecasi.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
InTec industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)
- akta.pro secondary industries
- Hematology & Coagulation Diagnostics (HLAHAAAB), Home Diagnostic & Self-Test OTC Kits (HLAIADAO), Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)
Keywords
Where InTec is headquartered
LocationHeadquarters
- HQ city
- Xiamen
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
InTec business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- In Vitro Diagnostic Test Kit Sales: InTec generates revenue through the manufacture and sale of rapid diagnostic test kits and ELISA test kits to healthcare professionals, public health organizations, and government health programs globally
- Government and NGO Procurement: Large-scale procurement contracts with government health agencies and international organizations such as Ethiopian government tender of 24 million HIV tests, and products listed on Global Fund procurement list
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | B2B/Government procurement pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
InTec product offering
Product offeringCore offering
InTec manufactures and sells in vitro diagnostic tests, including rapid immunochromatographic assays (lateral flow tests) and ELISA test kits, for infectious disease screening (HIV, hepatitis, malaria, TORCH, STDs, and others) and blood group typing. The company supplies these diagnostic kits directly to healthcare professionals, hospitals, blood banks, government health agencies, and international procurement organizations such as the Global Fund.
Product overview
InTec is a manufacturer of in vitro diagnostic tests, rapid diagnostic tests, and ELISA test kits. The product portfolio consists of three core product lines: Blood Group Test Kits (including ABO/RhD products using solid-phase technology), Rapid Test Kits (lateral flow immunochromatographic assays for professional use covering 13 categories including Blood-Borne Disease, Hepatitis, STD, Respiratory, Vector-Borne Disease, Tuberculosis, Pregnancy, Gastrointestinal Disease, Drug of Abuse, Torch, Tumor Marker, COVID-19, and Cardiac Marker), and ELISA Test Kits (enzyme-linked immunosorbent assays for Blood Borne Disease, Hepatitis, STD, and ToRCH). The company also offers specialized combo tests combining multiple diagnostics, and WHO pre-qualified products for global health programs. Founded in 1989, InTec focuses on infectious disease screening at the point of care with over 35 years of experience.
Differentiator
Problem solved
Functional benefit
Products and services
- Blood Group Test Kits (ABO/RhD) Blood group identification kits using a solid-phase method for qualitative detection of ABO blood group system A/B antigens and Rh blood group system D antigens in fresh finger prick blood or anticoagulated venous whole blood, with 100% accuracy. Intended for blood banks and pre-transfusion testing.
- Rapid Test Kits Lateral flow immunochromatographic rapid diagnostic tests for professional use covering blood-borne disease, hepatitis, STD, respiratory, vector-borne disease, tuberculosis, pregnancy, gastrointestinal disease, drug of abuse, TORCH, tumor marker, COVID-19, and cardiac marker categories.
- ELISA Test Kits Enzyme-linked immunosorbent assay (ELISA) diagnostic kits for detection of blood-borne disease, hepatitis, STD, and ToRCH infections, designed for clinical laboratories.
- One Step Anti-HIV (1&2) Test WHO pre-qualified and CE-marked lateral flow rapid test for qualitative detection of antibodies to HIV-1 and HIV-2 with 100% sensitivity and 100% specificity, intended for professional diagnostic use.
- Rapid Anti-HCV Test CE-marked lateral flow anti-HCV rapid test with 99.7% sensitivity and 99.8% specificity for qualitative detection of hepatitis C virus antibodies.
- One Step Malaria (Pf) Test WHO prequalified and CE-marked rapid diagnostic test for detection of Plasmodium falciparum malaria antigen.
- One Step Malaria (Pf/Pv) Tri-line Test
Quantifiable outcome
- 100% Sensitivity and 100% Specificity for One Step Anti-HIV (1&2) Test
- +2 more outcomes
Companies that use InTec
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
InTec technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
InTec partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- World Hepatitis AlliancecorePartnership to find the missing millions - supporting global hepatitis elimination efforts through screening and diagnosis initiatives.
- World Health Organization (WHO)coreWHO pre-qualification for HIV, HCV, and Malaria rapid diagnostic tests. WHO prequalification enables InTec products to be procured by UN agencies and international financing bodies for global health programs.
- Global FundcoreInTec's HIV and HCV rapid tests are listed on the Global Fund procurement list, enabling access to funding for HIV and hepatitis programs in supported countries.
- Bill & Melinda Gates FoundationcoreMalaria partnership with Gates Foundation supporting global malaria control and elimination efforts through access to quality diagnostic tools.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
InTec competitors and assessment
Company assessmentDirect peers
- OraSure Technologies: US diagnostics company specializing in HIV self-tests (OraQuick) and rapid infectious disease tests — directly comparable on HIV self-test positioning and global health procurement.
- CTK Biotech: US/San Diego-based rapid IVD manufacturer with infectious disease lateral flow tests (malaria, HIV, dengue, hepatitis) sold primarily to emerging markets — comparable product mix and OEM/wholesale distribution model.
- Zhejiang Orient Gene Biotech: Chinese rapid diagnostic manufacturer with broad infectious disease and COVID-19 lateral flow portfolio and global export footprint — competes with InTec in similar product categories and geographies.
- SD Biosensor: Korean manufacturer of rapid diagnostic tests for infectious diseases (HIV, malaria, HCV, COVID-19) with WHO pre-qualification and Global Fund listings — directly comparable product portfolio and global health customer base to InTec.
- Access Bio: US/Korea-headquartered rapid diagnostic test maker focused on infectious disease screening (malaria, HIV, dengue) with strong emerging-market distribution — comparable product mix and global health program focus.
- Guangzhou Wondfo Biotech: China-based rapid IVD manufacturer with overlapping infectious disease lateral flow products (HIV, HCV, syphilis, malaria) and similar WHO pre-qualified offerings — the closest Chinese direct peer to InTec.
- Trinity Biotech: Ireland-based diagnostic company offering rapid point-of-care infectious disease tests (HIV, syphilis) and specialty diagnostics — overlapping customer base in emerging market public health programs.
- Chembio Diagnostics: US-based point-of-care diagnostic company with rapid tests for HIV, syphilis, and other infectious diseases — similar focus on decentralized, resource-limited settings.
Broad incumbents
- Bio-Rad Laboratories: Global life sciences and clinical diagnostics company with HIV and infectious disease screening products including rapid tests — broad incumbent that overlaps with InTec in blood-borne disease screening workflows.
- Abbott Diagnostics (formerly Alere): Global IVD incumbent with extensive rapid test portfolio (HIV, malaria, HCV) and large-scale global health business — competes with InTec in the same product categories but as part of a much broader diagnostic franchise.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
InTec social profiles
Digital presenceInTec compliance and trust
Trust signalCompliance3 records
InTec financial estimates
Financial estimateRevenue estimate
Valuation estimate
InTec leadership team
Management profileNumber of profiles
Profiles1 record
InTec funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InTec M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InTec
What does InTec do?
InTec manufactures and sells in vitro diagnostic tests, including rapid immunochromatographic assays (lateral flow tests) and ELISA test kits, for infectious disease screening (HIV, hepatitis, malaria, TORCH, STDs, and others) and blood group typing. The company supplies these diagnostic kits directly to healthcare professionals, hospitals, blood banks, government health agencies, and international procurement organizations such as the Global Fund.
Is InTec a public or private company?
InTec is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was InTec founded?
InTec was founded in 1989. It employs 11 to 50 people.
Where is InTec based?
InTec is headquartered in Xiamen, China, in the Asia region.
How does InTec make money?
Two revenue lines are on record. In Vitro Diagnostic Test Kit Sales are the primary driver. The others are government and NGO Procurement.
Who are InTec's main competitors?
Direct peers on record are OraSure Technologies, CTK Biotech, Zhejiang Orient Gene Biotech, SD Biosensor, Access Bio, Guangzhou Wondfo Biotech, Trinity Biotech and Chembio Diagnostics. Broad incumbents are Bio-Rad Laboratories and Abbott Diagnostics (formerly Alere).
Does InTec have an API?
No public API is recorded for InTec.
What industry is InTec in?
InTec's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAH, Blood Bank, Transfusion Medicine & Immunohematology, with a secondary code of HLAHAAAB, Hematology & Coagulation Diagnostics. Its NAICS code is 325413 and its SIC code is 2835.